April 6, 2011 – A pooled analysis of the SPIRIT II, III, IV and COMPARE trials further reinforces the positive ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
March 21, 2011 - OrbusNeich today announced it filed a lawsuit in the Netherlands against a doctor and principal ...
March 21, 2011
February 21, 2011 – Two drug-eluting coronary stent systems have been launched in India. Boston Scientific’s ...
February 21, 2011
February 21, 2011 – The first patient has been enrolled the DESSOLVE II study to support CE mark for a coronary ...
February 21, 2011
January 26, 2011 – Patient enrollment has begun in China for a trial evaluating the safety and effectiveness of a ...
January 26, 2011
January 24, 2011 – Patient enrollment was completed in the EVOLVE clinical trial, which is designed to assess the ...
January 24, 2011
January 20, 2011 – European CE mark approval was granted to expand the indication of Abbott’s Xience Prime ...
January 21, 2011
January 20, 2011 – Drug-coated stents hold promise as a safe and lasting solution for the treatment of clogged leg ...
October 10, 2011
January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting ...
January 10, 2011December 6, 2010 - A European court has struck a blow to Boston Scientific's alleged patent infringement case ...
December 06, 2010
September 28, 2010 – Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter ...
September 28, 2010
September 24, 2010 – Drug-eluting stents are beneficial in treating symptomatic peripheral artery disease (PAD) in ...
September 24, 2010
September 24, 2010 - Two-year data from the SPIRIT IV trial show that everolimus-eluting stents demonstrated ...
September 24, 2010
September 23, 2010 - Results from the second stage of a trial studying a bioresorbable vascular scaffold were ...
September 23, 2010
September 23, 2010 - Results from a study evaluating the safety and clinical efficacy of the Promus Element ...
September 23, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now